Spruce Biosciences, Inc. (SPRB)

Spruce Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-46.75	-47.92	-46.18	-42.29	-29.54	-13.09
Depreciation & Amortization	0.3	0.3	0.43	0.38	0.1	0.01
Share-Based Compensation	5.12	4.62	3.63	3.96	0.76	0.2
Other Operating Activities	4.89	9.72	0.44	2.08	1.16	0.26
Operating Cash Flow	-36.44	-33.28	-41.68	-35.88	-27.52	-12.62
Capital Expenditures	-0.01	-0.01	-0.01	-0.09	-0.07	-0
Change in Investments	45.3	55.78	23.7	-79.08	0	0
Investing Cash Flow	45.29	55.78	23.69	-79.17	-0.07	-0
Share Issuance / Repurchase	0.35	53.79	0.08	0.46	93.4	0
Debt Issued / Paid	-1.62	-1.62	0	0.22	0	4.49
Other Financing Activities	-0.34	-3.02	-0.32	-0.04	87.63	7.94
Financing Cash Flow	-1.62	49.14	-0.24	0.64	181.04	12.43
Net Cash Flow	7.23	71.64	-18.23	-114.4	153.44	-0.19
Free Cash Flow	-36.45	-33.28	-41.69	-35.97	-27.59	-12.62
Free Cash Flow Margin	-359.93%	-329.88%	-	-	-	-
Free Cash Flow Per Share	-0.89	-0.86	-1.77	-1.54	-4.61	-16.51

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).